Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CXCL16-mediated recruitment of γδ T cells to the brain reduces sociability in mice.

Science immunology·2026
Same author

Particle Design via Lactosome-Based Polycarboxybetaine Modification and Initial Evaluation of the Accelerated Blood Clearance Phenomenon.

Biological & pharmaceutical bulletin·2026
Same author

Evaluation of increased oxidative stress in the brain of patients with early Alzheimer's disease by <sup>64</sup>Cu-ATSM PET/MRI.

Journal of neural transmission (Vienna, Austria : 1996)·2025
Same author

Relationship between renal oxidative stress levels and disease severity in patients with chronic kidney disease assessed by [Cu-64]ATSM PET/MRI.

Scientific reports·2025
Same author

PET/MRI multimodality imaging to evaluate changes in glymphatic system function and biomarkers of Alzheimer's disease.

Scientific reports·2024
Same author

High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[<sup>18</sup>F]fluorothymidine positron emission tomography.

Annals of nuclear medicine·2023

Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.3K

Solid tumor-targeting theranostic polymer nanoparticle in nuclear medicinal fields.

Akira Makino1, Shunsaku Kimura2

  • 1Biomedical Imaging Research Center (BIRC), University of Fukui, Fukui 910-1193, Japan ; Research and Education Program for Life Science, University of Fukui, Fukui 910-1193, Japan.

Thescientificworldjournal
|November 8, 2014
PubMed
Summary

Polymer nanoparticles effectively deliver radionuclides for nuclear medicine imaging and therapy. These nanocarriers show promise for targeted solid tumor treatments and nanotheranostics.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.6K

Related Experiment Videos

Last Updated: Apr 21, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.3K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.6K

Area of Science:

  • Nuclear medicine
  • Polymer science
  • Nanotechnology

Background:

  • Amphiphilic polymer self-assembly forms nanoparticles for drug delivery systems (DDS).
  • Polymer nanoparticles are explored as carriers for diagnostic and therapeutic agents.
  • Radionuclides are crucial for diagnostic imaging (PET, SPECT) and radionuclide therapy.

Purpose of the Study:

  • To review recent advancements in solid tumor-targeting polymer nanoparticles for nuclear medicine.
  • To highlight the potential of polymer nanoparticles as carriers for radionuclides in nanotheranostics.

Main Methods:

  • Review of literature on polymer nanoparticle synthesis and characterization.
  • Analysis of studies on the application of polymer nanoparticles in nuclear medicine for solid tumors.
  • Discussion of nanotheranostic approaches utilizing polymer nanoparticles with radionuclides.

Main Results:

  • Polymer nanoparticles can encapsulate various diagnostic and therapeutic radionuclides.
  • Designed polymer nanoparticles demonstrate efficacy in targeting solid tumors.
  • Nanotheranostic applications combining diagnosis and therapy are emerging.

Conclusions:

  • Polymer nanoparticles are promising DDS carriers for radionuclides in nuclear medicine.
  • These nanocarriers facilitate the development of targeted therapies and advanced nanotheranostics for solid tumors.